Sanofi traded at 96.92 this Tuesday July 5th, decreasing 1.42 or 1.44 percent since the previous trading session. Looking back, over the last four weeks, Sanofi lost 3.23 percent. Over the last 12 months, its price rose by 11.70 percent. Looking ahead, we forecast Sanofi to be priced at 94.02 by the end of this quarter and at 84.25 in one year, according to Trading Economics global macro models projections and analysts expectations.

Stock Price
97.41
Daily Change
-0.95%
Yearly
12.26%

Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
AbbVie 153.80 0.64 0.42% 33.54%
Aena 123.50 -1.75 -1.40% -12.87%
Alcon AG 68.04 0.08 0.12% 4.23%
Almirall SA 10.85 0.06 0.56% -28.15%
Amgen 245.55 2.25 0.92% -1.27%
Amarin 1.44 -0.05 -3.36% -67.20%
Artemis Alpha 298.61 2.07 0.70% -33.05%
AstraZeneca 10,782.00 -26.00 -0.24% 23.63%
Bayer 56.49 -0.75 -1.31% 11.46%
Biogen 210.63 6.69 3.28% -39.60%
BMW 72.46 -0.33 -0.45% -15.77%
Bristol-Myers Squibb 76.84 -0.16 -0.21% 14.77%
Daimler 52.82 -0.63 -1.18% -27.55%
Vinci 84.99 -1.41 -1.63% -7.19%
Essilor 139.70 -0.10 -0.07% -7.85%
Fresenius Medical Care 47.76 0.10 0.21% -29.45%
Fresenius 29.17 -0.15 -0.51% -33.43%
Genmab 2,381.00 28.00 1.19% -9.40%
Gilead Sciences 62.36 0.55 0.89% -10.01%
Galapagos 53.42 0.36 0.68% -7.64%
GRIFOLS 17.60 -0.24 -1.32% -21.43%
GlaxoSmithKline 1,789.20 -13.40 -0.74% 24.75%
Hikma Pharmaceutical 1,638.00 -16.00 -0.97% -35.94%
J&J 179.52 2.01 1.13% 6.24%
Eli Lilly 324.71 0.48 0.15% 38.79%
Lonza Group 537.80 13.00 2.48% -19.23%
Merck 166.60 1.20 0.73% 0.63%
Merck & Co 92.42 1.25 1.37% 17.58%
Novartis 81.30 -0.35 -0.43% -3.43%
Orion 43.03 0.28 0.66% 16.11%
Pfizer 52.31 -0.12 -0.23% 31.66%
Philips 19.96 -0.18 -0.90% -50.39%
Recordati 42.88 -0.14 -0.33% -14.41%
Regeneron Pharmaceuticals 595.40 4.27 0.72% 2.01%
Roche Holding 320.15 -2.45 -0.76% -9.43%
Sanofi 97.41 -0.93 -0.95% 12.26%
SAP 85.43 -0.01 -0.01% -28.99%
UCB 82.34 -0.30 -0.36% -7.21%
Volkswagen 124.52 -2.48 -1.95% -38.66%

Indexes Price Day Year
EU50 3424 -28.34 -0.82% -15.51%
FR40 5887 -68.09 -1.14% -9.54%
EU100 1145 -9.43 -0.82% -9.47%

Sanofi
Sanofi SA is a healthcare company based in France. The Company focuses on patient needs and engages in the research, development, manufacture, and marketing of therapeutic solutions. Its three operating segments are: Pharmaceuticals, Consumer Healthcare (CHC), and Vaccines. The Pharmaceuticals includes: Immunology, Multiple Sclerosis / Neurology, Oncology, Rare Diseases, Rare Blood Disorders, Cardiovascular, Diabetes, Established Prescription Products. The Vaccines segment comprises, for all geographical territories, the commercial operations of Sanofi Pasteur, together with research, development, and production activities dedicated to vaccines. The CHC segment comprises the commercial operations for Sanofi’s Consumer Healthcare products, together with research, development and production activities dedicated to those products. The Company’s products developed in collaboration or franchise include Dupixent, Aubagio, Lemtrada, Cerezyme, Lumizyme, Jevtana, Fabrazyme, among others.